Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Klinisk tillämpning av höger visuell dubbellumentub i torakoskopisk kirurgi för vuxna patienter (RIGHT-VDLT)

13 augusti 2026 uppdaterad av: Diansan Su

Jämförelse av klinisk tillämpning av höger visuell dubbellumens tub och höger vanlig dubbellumens tub i torakoskopisk kirurgi för vuxna patienter

Denna kliniska studie syftar till att förstå om ett visuellt dubbellumensintubationsrör kan förbättra framgångsgraden vid första försöket och minska komplikationer jämfört med ett standard dubbellumensrör. Studien syftar främst till att besvara följande frågor:

Förbättrar ett dubbellumensrör framgångsgraden vid första försöket?

Minskar ett visuellt dubbellumensrör risken för obstruktion av den högra övre lobbronkens öppning?

Kräver ett visuellt dubbellumensrör färre justeringar under operationen?

Upplever patienter med visuella dubbellumensrör färre perioperativa komplikationer jämfört med dem som har standard dubbellumensrör?

Deltagarna kommer att:

Använda ett visuellt dubbellumensrör delvis och ett standard dubbellumensrör delvis.

Registrera perioperativt tillstånd för alla patienter.

Studieöversikt

Detaljerad beskrivning

Right-sided double-lumen tubes are used to achieve lung isolation and one-lung ventilation during thoracoscopic surgery. Accurate positioning is particularly important because of the short right main bronchus and the need to maintain patency of the right upper-lobe bronchial opening. Malposition or displacement of a right-sided double-lumen tube may impair right upper-lobe ventilation, compromise lung isolation, and require repeated tube repositioning or fibreoptic bronchoscopy.

This prospective, multicentre, parallel-group randomised controlled trial will enrol 566 adult participants undergoing elective thoracoscopic surgery requiring one-lung ventilation with a right-sided double-lumen tube. Participants will be randomly allocated in a 1:1 ratio to either a video-guided right-sided double-lumen tube or a conventional right-sided double-lumen tube.

In the video-guided group, an integrated visualisation system provides continuous airway visual feedback during initial tube positioning and intraoperative monitoring, allowing real-time identification of changes in tube position. In the conventional group, initial tube placement is performed using standard clinical techniques and anatomical landmarks.

After initial positioning, final tube position will be confirmed by fibreoptic bronchoscopy in both groups. Subsequent fibreoptic bronchoscopy during one-lung ventilation will be performed only when clinically indicated or according to predefined rescue criteria.

The primary outcome is successful initial right-sided double-lumen tube placement, defined as placement of the assigned tube on the first intubation attempt with satisfactory final tube position and satisfactory lung isolation, without withdrawal and reinsertion or exchange to another airway device before initiation of one-lung ventilation.

Secondary outcomes include the incidence of right upper-lobe bronchial obstruction confirmed by fibreoptic bronchoscopy; incidence of intraoperative double-lumen tube displacement; incidence of hypoxemia during one-lung ventilation; requirement for rescue fibreoptic bronchoscopy; time to satisfactory right-sided double-lumen tube positioning; quality of operative lung collapse assessed by the operating surgeon; and the number of intraoperative tube repositioning events.

Participants and outcome assessors will remain blinded to treatment allocation. Because the video-guided and conventional right-sided double-lumen tubes have distinct visual and operational characteristics, the anaesthesiologist performing tracheal intubation and other intraoperative personnel directly involved in airway management cannot be blinded. Outcome assessment will be performed by personnel who are not involved in the airway intervention and remain unaware of treatment allocation.

The trial is designed to determine whether continuous airway visualisation improves initial placement success, maintains more stable right-sided double-lumen tube positioning, reduces the need for subsequent airway interventions, and improves clinically relevant conditions during one-lung ventilation.

Studietyp

Interventionell

Inskrivning (Beräknad)

566

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

    • Zhejiang
      • Hangzhou, Zhejiang, Kina, 310000
        • Rekrytering
        • The First Affiliated Hospital, Zhejiang University School of Medicine,
        • Kontakt:
          • Heng Wen
      • Jiaxing, Zhejiang, Kina, 314000
        • Rekrytering
        • Affiliated Hospital of Jiaxing University(The First Hospital of Jiaxing)
      • Jiaxing, Zhejiang, Kina, 314000
        • Har inte rekryterat ännu
        • The Second Affiliated Hospital of Jiaxing University(The Second Hospital of Jiaxing)

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Beskrivning

Inklusionskriterier:

  • Ålder: minst 18 år, kön är inte begränsat.
  • American Anesthesiologists Association (ASA) klass I-III;
  • Planerad videobröstad torakoskopisk lobektomi.
  • Informerat samtycke från patienten eller familjemedlem.
  • Personer som är villiga att acceptera perioperativa besök.

Exklusionskriterier:

  • Patienter med kontraindikationer för insättning av höger dubbellumenstub (såsom tumör i höger bronk).
  • Patienten har kända trakeobronkiella anatomiska avvikelser.
  • Patienter som tidigare diagnostiserats eller misstänkts ha luftvägssvårigheter.
  • Patienter som behöver snabb sekvensinduktion.
  • Patienter som kräver akutoperation.
  • Patienter som genomgått toraxkirurgi, systemisk infektion eller misstänkt tuberkulos under de senaste fyra veckorna.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Dubbel

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Video-guided right-sided double-lumen tube
Participants undergo lung isolation for thoracoscopic surgery using a video-guided right-sided double-lumen tube. The integrated camera provides continuous airway visualisation to facilitate initial positioning and intraoperative detection of tube displacement. Final tube position is confirmed by fibreoptic bronchoscopy after initial positioning. Subsequent fibreoptic bronchoscopy during one-lung ventilation is performed only when clinically indicated or according to predefined rescue criteria.
A right-sided double-lumen tube with an integrated visualisation system that provides continuous airway visual feedback during placement and intraoperative monitoring. Fibreoptic bronchoscopy is used to confirm final tube position after initial positioning and remains available as a rescue technique when clinically indicated.
Aktiv komparator: Conventional right-sided double-lumen tube
A conventional right-sided double-lumen tube used for lung isolation. Initial placement is performed using standard clinical techniques and anatomical landmarks. Fibreoptic bronchoscopy is used to confirm final tube position after initial positioning and remains available as a rescue technique when clinically indicated.
A conventional right-sided double-lumen tube used for lung isolation. Initial placement is performed using standard clinical techniques and anatomical landmarks. Fibreoptic bronchoscopy is used to confirm final tube position after initial positioning and remains available as a rescue technique when clinically indicated.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Successful initial right-sided double-lumen tube placement
Tidsram: From initial insertion of the assigned right-sided double-lumen tube until confirmation of satisfactory tube position before initiation of one-lung ventilation (approximately 10 minutes).
Successful initial placement is defined as placement of the assigned right-sided double-lumen tube on the first intubation attempt, with satisfactory final tube position and satisfactory lung isolation, without withdrawal and reinsertion or exchange to another airway device before initiation of one-lung ventilation.
From initial insertion of the assigned right-sided double-lumen tube until confirmation of satisfactory tube position before initiation of one-lung ventilation (approximately 10 minutes).

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Incidence of right upper-lobe bronchial obstruction
Tidsram: After initial tube positioning and before initiation of one-lung ventilation (approximately 10 minutes).
Right upper-lobe bronchial obstruction is defined as partial or complete obstruction of the right upper-lobe bronchial opening by the bronchial lumen or bronchial cuff after initial tube positioning, as confirmed by fibreoptic bronchoscopy. The outcome will be recorded as present or absent.
After initial tube positioning and before initiation of one-lung ventilation (approximately 10 minutes).
Incidence of intraoperative double-lumen tube displacement
Tidsram: From initiation of one-lung ventilation until completion of one-lung ventilation.
Tube displacement is defined as any intraoperative displacement of the double-lumen tube that requires repositioning to restore satisfactory tube position, ventilation, or lung isolation. The outcome will be recorded as present or absent.
From initiation of one-lung ventilation until completion of one-lung ventilation.
Incidence of hypoxemia during one-lung ventilation
Tidsram: During one-lung ventilation.
Hypoxemia is defined as peripheral oxygen saturation (SpO₂) <90% during one-lung ventilation. The outcome will be recorded as present or absent.
During one-lung ventilation.
Requirement for rescue fibreoptic bronchoscopy
Tidsram: From completion of initial tube positioning until completion of one-lung ventilation.
Rescue fibreoptic bronchoscopy is defined as fibreoptic bronchoscopy performed after initial tube positioning because of suspected tube malposition, inadequate lung isolation, ventilation abnormality, or need for tube repositioning. The outcome will be recorded as present or absent.
From completion of initial tube positioning until completion of one-lung ventilation.
Time to satisfactory right-sided double-lumen tube positioning
Tidsram: During initial tube placement after anaesthesia induction (approximately 10 minutes).
Time from removal of the stylet after the bronchial cuff passes the vocal cords to confirmation of satisfactory right-sided double-lumen tube position. The duration will be recorded in seconds.
During initial tube placement after anaesthesia induction (approximately 10 minutes).
Quality of operative lung collapse
Tidsram: 20 minutes after initiation of one-lung ventilation.
The operating surgeon, blinded to treatment allocation, will assess operative lung collapse using a three-category scale: excellent (complete collapse with optimal surgical exposure), good (minor residual inflation without interference with surgery), or poor (incomplete collapse interfering with surgical exposure).
20 minutes after initiation of one-lung ventilation.
Number of intraoperative double-lumen tube repositioning events
Tidsram: From initiation of one-lung ventilation until completion of one-lung ventilation.
The number of separate tube repositioning procedures required after satisfactory initial placement will be recorded for each participant.
From initiation of one-lung ventilation until completion of one-lung ventilation.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

30 maj 2026

Primärt slutförande (Beräknad)

24 december 2026

Avslutad studie (Beräknad)

1 mars 2027

Studieregistreringsdatum

Först inskickad

7 januari 2026

Först inskickad som uppfyllde QC-kriterierna

14 januari 2026

Första postat (Faktisk)

23 januari 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 augusti 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

13 augusti 2026

Senast verifierad

1 augusti 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

Individual participant data will not be shared because of participant privacy considerations and the restrictions of the informed consent and ethics approval.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera